Are face-to-face medical meetings a thing of the past?Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception. Share XAre face-to-face medical meetings a thing of the past?https://pharmaphorum.com/views-and-analysis/are-face-to-face-medical-meetings-a-thing-of-the-past/
‘No going back’ for clinical trials after COVIDTrial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as Share X‘No going back’ for clinical trials after COVIDhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/no-going-back-for-clinical-trials-after-covid/
2021 – UK market access prospectsWith a new year comes the opportunity to think ahead for the market access landscape for the coming Share X2021 – UK market access prospectshttps://pharmaphorum.com/views-analysis-market-access/2021-uk-market-access-prospects/
2021 – The healthcare changes here to stay2020 was the year that changed everything, and as the new year begins many are wondering what awaits Share X2021 – The healthcare changes here to stayhttps://pharmaphorum.com/views-analysis-digital/2021-healthcare-change/
How patient insights are changing trial solutionsPatients have been asking for patient-centric trial solutions for years – the industry just hasn’t been listening. That’s Share XHow patient insights are changing trial solutionshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/how-patient-insights-are-changing-trial-solutions/
COVID-19 and the digital pharma marketing revolutionThe global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world Share XCOVID-19 and the digital pharma marketing revolutionhttps://pharmaphorum.com/views-analysis-sales-marketing/covid-19-and-the-digital-pharma-marketing-revolution/
Resourceful or risky? The UK’s controversial COVID-19 vaccine strategyAs COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s Share XResourceful or risky? The UK’s controversial COVID-19 vaccine strategyhttps://pharmaphorum.com/r-d/views-analysis-r-d/resourceful-or-risky-the-uks-controversial-covid-19-vaccine-strategy/
True patient-focused research through decentralised and hybrid trialsHow can pharma improve the patient-centricity of its trials during COVID-19 and beyond? Experts from across the sector Share XTrue patient-focused research through decentralised and hybrid trialshttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/true-patient-focused-research-through-decentralised-and-hybrid-trials/
The Alderley Park Discovery Podcast: Life science skills, staffing and supportEpisode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with Share XThe Alderley Park Discovery Podcast: Life science skills, staffing and supporthttps://pharmaphorum.com/podcast/alderley-park-life-science-skills-staffing/